Tonghua Huikang Biopharmaceutical

Tonghua Huikang Biopharmaceutical is a Chinese biotechnology company based in Tonghua, Jilin Province, specializing in the development and large-scale manufacturing of recombinant human insulin and its analogues. As a core subsidiary of Tonghua Dongbao Pharmaceutical, the company operates advanced production lines for biological drugs targeting metabolic disorders, particularly diabetes mellitus. Its capabilities include high-capacity fermentation, purification, and formulation of insulin glargine, insulin aspart, and other recombinant proteins. The company is a key player in China's domestic insulin market and contributes significantly to the vertical integration of its parent group's biopharmaceutical operations. Tonghua Huikang maintains strict adherence to GMP standards to support both domestic supply and international expansion.